Format
Sort by
Items per page

Send to

Choose Destination

Best matches for DOXORUBICIN/AE:

Molecular mechanism of doxorubicin-induced cardiomyopathy - An update. Renu K et al. Eur J Pharmacol. (2018)

Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity. Liu H et al. Mini Rev Med Chem. (2017)

Doxorubicin targets multiple players: A new view of an old problem. Cappetta D et al. Pharmacol Res. (2018)

Search results

Items: 1 to 20 of 10930

1.

Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Versus Radioembolization (TARE) for Patients With Colorectal Cancer Liver Metastases.

Mokkarala M, Noda C, Malone C, Ramaswamy R, Akinwande O.

Anticancer Res. 2019 Jun;39(6):3071-3077. doi: 10.21873/anticanres.13442.

PMID:
31177151
2.

Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: A meta-analysis and clinical observation.

Yu D, Zhang S, Feng A, Xu D, Zhu Q, Mao Y, Zhao Y, Lv Y, Han C, Liu R, Tian Y.

Medicine (Baltimore). 2019 May;98(19):e15582. doi: 10.1097/MD.0000000000015582.

3.

Interdigitating dendritic cell sarcoma of the spleen with hepatic failure after chemotherapy: A case report.

Zhao C, Xie X, Gai DZ, Wu D, Xin H, Yang T.

Medicine (Baltimore). 2019 May;98(19):e15535. doi: 10.1097/MD.0000000000015535.

4.

Ecotoxicological assessment and electrochemical remediation of doxorubicin.

Moreno EKG, Garcia LF, Lobón GS, Brito LB, Oliveira GAR, Luque R, de Souza Gil E.

Ecotoxicol Environ Saf. 2019 Sep 15;179:143-150. doi: 10.1016/j.ecoenv.2019.04.050. Epub 2019 Apr 28.

PMID:
31035248
6.

NH4Cl treatment prevents doxorubicin-induced myocardial dysfunction in vivo.

Huang X, Liu Y, Yang X, Lai S, Zhang Y, Gu J, Li H, Xie Y, Xia Y.

Life Sci. 2019 Jun 15;227:94-100. doi: 10.1016/j.lfs.2019.04.044. Epub 2019 Apr 18.

PMID:
31004659
7.

Regulation of P-glycoprotein by Bajijiasu in vitro and in vivo by activating the Nrf2-mediated signalling pathway.

Yang X, Hu G, Lv L, Liu T, Qi L, Huang G, You D, Zhao J.

Pharm Biol. 2019 Dec;57(1):184-192. doi: 10.1080/13880209.2019.1582679.

8.

Low doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblasts.

Quagliariello V, Coppola C, Mita DG, Piscopo G, Iaffaioli RV, Botti G, Maurea N.

Environ Toxicol Pharmacol. 2019 Jul;69:1-8. doi: 10.1016/j.etap.2019.03.006. Epub 2019 Mar 7.

PMID:
30903913
9.

Polyelectrolyte Carboxymethyl Cellulose for Enhanced Delivery of Doxorubicin in MCF7 Breast Cancer Cells: Toxicological Evaluations in Mice Model.

Shafiei-Irannejad V, Rahimi M, Zarei M, Dinparast-Isaleh R, Bahrambeigi S, Alihemmati A, Shojaei S, Ghasemi Z, Yousefi B.

Pharm Res. 2019 Mar 18;36(5):68. doi: 10.1007/s11095-019-2598-3.

PMID:
30887127
10.

Effects of steroidal saponins extract from Ophiopogon japonicus root ameliorates doxorubicin-induced chronic heart failure by inhibiting oxidative stress and inflammatory response.

Wu Z, Zhao X, Miyamoto A, Zhao S, Liu C, Zheng W, Wang H.

Pharm Biol. 2019 Dec;57(1):176-183. doi: 10.1080/13880209.2019.1577467.

12.

β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB2) receptors in rats.

Meeran MFN, Al Taee H, Azimullah S, Tariq S, Adeghate E, Ojha S.

Chem Biol Interact. 2019 May 1;304:158-167. doi: 10.1016/j.cbi.2019.02.028. Epub 2019 Mar 2.

PMID:
30836069
13.

Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?

Ruff C, Grözinger G, Syha R, Elser S, Partovi S, Bitzer M, Horger M, Nikolaou K, Grosse U.

J Vasc Interv Radiol. 2019 Mar;30(3):380-389.e4. doi: 10.1016/j.jvir.2018.09.001.

PMID:
30819480
14.

Oxidative stress injury in doxorubicin-induced cardiotoxicity.

Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S.

Toxicol Lett. 2019 Jun 1;307:41-48. doi: 10.1016/j.toxlet.2019.02.013. Epub 2019 Feb 25. Review.

PMID:
30817977
15.

Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathway.

Tomlinson L, Lu ZQ, Bentley RA, Colley HE, Murdoch C, Webb SD, Cross MJ, Copple IM, Sharma P.

Biomed Pharmacother. 2019 Apr;112:108637. doi: 10.1016/j.biopha.2019.108637. Epub 2019 Feb 22.

16.
17.

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.

Zaheed M, Wilcken N, Willson ML, O'Connell DL, Goodwin A.

Cochrane Database Syst Rev. 2019 Feb 18;2:CD012873. doi: 10.1002/14651858.CD012873.pub2.

PMID:
30776132
18.

[A Case of Drug-Induced Interstitial Lung Disease Associated with Epirubicin and Cyclophosphamide Therapy before Operation].

Omoto H, Takada M, Fujii S, Ito H, Yamashita S.

Gan To Kagaku Ryoho. 2019 Jan;46(1):160-162. Japanese.

PMID:
30765674
19.

Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP.

Kari E, Teppo HR, Haapasaari KM, Kuusisto MEL, Lemma A, Karihtala P, Pirinen R, Soini Y, Jantunen E, Turpeenniemi-Hujanen T, Kuittinen O.

J Clin Pathol. 2019 Apr;72(4):316-321. doi: 10.1136/jclinpath-2018-205584. Epub 2019 Feb 12.

20.

Genistein protects against doxorubicin-induced cardiotoxicity through Nrf-2/HO-1 signaling in mice model.

Bai Z, Wang Z.

Environ Toxicol. 2019 May;34(5):645-651. doi: 10.1002/tox.22730. Epub 2019 Feb 7.

PMID:
30734460

Supplemental Content

Loading ...
Support Center